Afynia Laboratories is a Canadian FemTech company focused on developing innovative diagnostic solutions for women’s health, particularly endometriosis. Originally known as AIMA Laboratories, the company emerged from McMaster University in Ontario and is led by Dr. Lauren Foster, a respected scientist in the field.

The company is known for its home test designed to simplify and expedite the diagnosis of endometriosis, which can often take years. Afynia has developed a blood test that utilizes microRNA biomarkers to detect the condition more accurately and quickly. This approach aims to improve patient outcomes by providing timely access to treatments and reducing healthcare costs.

Afynia Laboratories has secured significant funding to support its mission, including a $5 million seed funding round in 2025. The leadership team comprises experts in science, medicine, and finance, all dedicated to enhancing women’s health through innovative diagnostics.